Case Studies

Bladder Cancer
95 PET/CT for the Initial Staging Work-up  
   
Breast Cancer
46
66
67
80
79
90
84
105
PET/CT Extent of Disease Within the Breast
PET/CT to Stage Breast Cancer
PET/CT to Stage Locally Advanced Breast Cancer
PET/CT for Post-Surgical Staging
Whole Body PET/CT Staging in Multifocal Breast Cancer
PET/CT throughout the Course of Treatment for Inflammatory Breast Cancer
PET/CT to Identify a Non-Responder
PET/CT Accuracy Relative to Conventional Imaging
   
Gynecologic Cancers
55
98
104
Cervical Cancer: PET/CT to Direct the Course of Therapy
Uterine Cancer: PET/CT to Identify the Extent of Recurrence
Ovarian Cancer: PET/CT for Detection of Recurrence
   
Colorectal Cancer
70
52
87
63
86
57
Colon Cancer: PET/CT for Post-Surgical Staging
Rectal Cancer: PET/CT for Directing the Biopsy and the Course of Treatment
Colon Cancer: PET/CT to Manage Metastatic Disease
Rectal Cancer: PET/CT vs Conventional Imaging
Colon Cancer: PET/CT to Follow Liver Metastases
Colon Cancer: PET/CT to Restage after Chemotherapy
   
Esophageal Cancer
49
89
PET/CT to Assess the Response to Therapy
PET/CT to Guide the Course of Therapy
   
Head and Neck Cancer
102
71
44
53
100
101
PET/CT for Initial Staging Work-up
PET/CT to Stage Head and Neck Cancer
PET/CT in the Unknown Primary Cancer
PET/CT to Direct the Course of Treatment
PET/CT for Whole Body Evaluation in Laryngeal Cancer
PET/CT for Detection of Second Primary Cancers
   
Lymphoma
43
76
91
92
65
PET/CT to Track the Response to Therapy
PET/CT to Direct the Course of Therapy in Burkitt’s Lymphoma
PET/CT to Guide the Course of Therapy in Non-Hodgkin’s Lymphoma
PET/CT to Assess Response to Therapy Residual Mass - Hodgkin’s Lymphoma
PET/CT to Restage Cutaneous Lymphoma
   
Melanoma
62
48
PET/CT to Stage Melanoma
PET/CT to Restage Melanoma
   
Multiple Myeloma
96 PET/CT to Restage Myeloma
   
Non-Small Cell Lung Cancer
106
50
54
83
85
45
PET/CT Accuracy Relative to Conventional Imaging
PET/CT to Direct the Course of Therapy
PET/CT to Assess the Response to Therapy
PET/CT to Identify Interval Development of Disease
PET/CT to Identify a Non-Responder
PET/CT in NSCLC Recurrence
   
Pancreatic Cancer
75 PET/CT to Diagnose Pancreatic Cancer
   
Prostate Cancer
93
94
PET/CT for the Initial Staging  Work-up
PET/CT to Restage a Patient with a Rising PSA
   
Radiation Therapy Planning
56 PET/CT for Radiation Therapy Planning in Head and Neck Cancer
   
Renal Cell Carcinoma
97 PET/CT to Restage Renal Cell Carcinoma
   
Sarcoma
74
81
PET/CT to Stage Leiomyosarcoma
PET/CT to Evaluate Progression of Disease
   
Solitary Pulmonary Nodules
47
64
99
PET/CT to Characterize an SPN
PET/CT for SPN in Patient with History of Cancer
PET/CT Following Bronchoscopy
   
Thyroid Cancer
51 PET/CT in the Detection of Recurrence
   

Algorithms